15.81  0.01 (0.06%)		01-24 16:00
Open: 15.73 High: 15.98 Volume: 1,283,680		Pre. Close: 15.8 Low: 15.63 Market Cap: 727(M)

Short term
Mid term
Targets	6-month :	19.5	1-year :	20.73
Resists	First :	16.69	Second :	17.75
Pivot price	15.74
Supports	First :	14.98	Second :	12.47
MAs	MA(5) :	15.91	MA(20) :	15.78
	MA(100) :	20.05	MA(250) :	20.16
MACD	MACD :	-0.5	Signal :	-0.6
%K %D	K(14,3) :	62.6	D(3) :	70.1
RSI	RSI(14): 40.5
52-week	High :	25.36	Low :	14.98

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ AVNS ] has closed below upper band by 43.1%. Bollinger Bands are 63.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	16 - 16.09	16.09 - 16.17
Low:	15.39 - 15.51	15.51 - 15.62
Close:	15.64 - 15.81	15.81 - 15.97

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Thu, 23 Jan 2025
Reasons to Hold Avanos Medical Stock in Your Portfolio Now - Yahoo Finance

Mon, 20 Jan 2025
Avanos Medical, Inc. (NYSE:AVNS) Short Interest Update - MarketBeat

Mon, 13 Jan 2025
Avanos Medical (NYSE:AVNS) Reaches New 52-Week Low - Here's What Happened - MarketBeat

Mon, 06 Jan 2025
AVNS - Avanos Medical, Inc. Latest Stock News & Market Updates - StockTitan

Mon, 06 Jan 2025
Avanos Medical CEO to Present at J.P. Morgan Healthcare Conference 2024 - StockTitan

Mon, 06 Jan 2025
Avanos Medical, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Finansavisen

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Devices
Shares Out	46 (M)
Shares Float	42 (M)
Held by Insiders	2.9 (%)
Held by Institutions	96.1 (%)
Shares Short	728 (K)
Shares Short P.Month	552 (K)

EPS	0.46
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	26.72
Profit Margin	2.2 %
Operating Margin	9.6 %
Return on Assets (ttm)	2 %
Return on Equity (ttm)	1.7 %
Qtrly Rev. Growth	-0.5 %
Gross Profit (p.s.)	0
Sales Per Share	14.82
EBITDA (p.s.)	2.22
Qtrly Earnings Growth	0 %
Operating Cash Flow	56 (M)
Levered Free Cash Flow	140 (M)

PE Ratio	33.63
PEG Ratio	0
Price to Book value	0.59
Price to Sales	1.06
Price to Cash Flow	13.09

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.